← Leaderboards
Angela Isabel Calderon
Auburn University At Auburn
$952,701
Attributed
$952,701
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $440.6K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$952,701 · 3
By mechanism
R15$440,590 · 1
S10$348,724 · 1
R03$163,387 · 1
Top collaborators
No co-investigators on record.
Most similar at Auburn University At Auburn
Same institution · by research overlap
- Kabre Heck$54,852
- Benson Tokunbo Akingbemi$684,140
Others in their field
Other Emerging Leaders on “Natural Products”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
Research focus
Natural ProductsPreparationAdverse EventInstrumentationCytochrome P450Pharmacy FacilityClinically RelevantDrug KineticsFundingInstitutionCore FacilityMetabolismPharmaceutical PreparationsPharmacologyEnzymesBotanicalsCessation Of LifeDrug InteractionsAffectFoundationsInnovationInsightMediatingReporting
Grant awards (4)
A shared Agilent 6546 LC-QTOF for biomedical research$348,724
S10 · FY2025 · OD · contact PI
In vitro assessment of kratom pharmacokinetic CYP interactions with HIV ART drug metabolism$75,159
R03 · FY2024 · DA · contact PI
In vitro assessment of kratom pharmacokinetic CYP interactions with HIV ART drug metabolism$88,228
R03 · FY2023 · DA · contact PI
Unravelling the mechanism of acai BDS-anticancer drug interaction: A preliminary approach$440,590
R15 · FY2021 · AT · contact PI